REporting recommendations for tumour MARKer prognostic studies (REMARK)
2005
Guidelines for Tumor Marker Studies
Editorial
Author Information
Author(s): Harris A L
Primary Institution: Cancer Research UK
Conclusion
The editorial emphasizes the need for standardized reporting and validation in tumor marker studies to improve their reliability and clinical relevance.
Supporting Evidence
- Standardized reporting can help improve the reliability of tumor marker studies.
- Many small studies lack the power to adequately test the significance of new markers.
- Validation of assays is crucial for the reproducibility of results.
Takeaway
This article talks about how important it is to have clear rules for studying cancer markers so that doctors can better understand which treatments will work for patients.
Potential Biases
There is a risk of bias due to poorly validated assays and variability in study designs.
Limitations
The editorial notes that many studies are small and lack the statistical power needed to validate findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website